MAM
ENGN icon

Marquette Asset Management’s enGene Therapeutics ENGN Stock Holding History

Marquette Asset Management’s Portfolio ENGN Stock Details ENGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
+150,546
New +$614K 0.03% 83

Other funds holding ENGN

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Marquette Asset Management's ENGN Position: Q2 2026 in Review

Marquette Asset Management opened a new position in enGene Therapeutics (ENGN) in Q2 2026: 150,546 shares worth $260K. The stake represents 0.03% of the portfolio and ranks #83 among its holdings.

2 funds tracked by Wall St. Rank hold ENGN as of Q2 2026.

  • Marquette Asset Management held 150,546 shares of enGene Therapeutics worth $260K as of Q2 2026.
  • enGene Therapeutics was a new Marquette Asset Management position in Q2 2026.
  • enGene Therapeutics made up 0.03% of Marquette Asset Management's portfolio in Q2 2026, its #83 holding.
  • 2 funds tracked by Wall St. Rank held enGene Therapeutics as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.